- Olema Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Olema Pharmaceuticals Inc Palazestrant Phase 2 Monotherapy Clinical Update Presentation TranscriptOct 23, 2023
- Olema Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Olema Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Olema Pharmaceuticals Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Olema Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Olema Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2023
- G1 Therapeutics Inc, Molecular Templates Inc, Olema Pharmaceuticals Inc and Puma Biotechnology Inc at Cowen Health Care Conference- Panel TranscriptMar 07, 2023
- Olema Pharmaceuticals Inc at Citi Virtual Oncology Leadership Summit TranscriptFeb 23, 2023
- Olema Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Olema Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Olema Pharmaceuticals Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Olema Pharmaceuticals Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Olema Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Olema Pharmaceuticals Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- Olema Pharmaceuticals Inc to Review the Phase 1 Clinical Data for OP-1250 TranscriptNov 30, 2021
- Olema Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
G1 Therapeutics Inc, Molecular Templates Inc, Olema Pharmaceuticals Inc and Puma Biotechnology Inc at Cowen Health Care Conference- Panel Transcript
Okay. I think we'll get started. Welcome back to the Cowen Healthcare Conference. Really happy to have -- next up with a panel discussion of various development programs companies in the breast and lung cancer space. And over to my side here, we have Jack Bailey from G1 Therapeutics; Filip Janku, the CMO from Monte Rosa; Eric Poma, CEO of Molecular Templates; Shane Kovacs, the COO and CFO of Olema Oncology; as well as Alan Auerbach, CEO of Puma.
Maybe to start off, we're going to start the conversation with some general topics that hopefully are a bit interactive between the various company representatives. And then we will dive into some company-specific questions. I think Joe is going to lead off with one of the general questions.
Questions & Answers
Thanks, Mark. And just a reminder for the audience, if you do have any questions for our panelists, feel free to e-mail us at [email protected], and we can try and get those into the discussion. But maybe just to start off, we've seen a couple of instances over the past
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)